Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PVH stock price vs OPK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OPK's multiple
Needs OPK P/E.
Implied fair value · at PVH's multiple
Needs EPS (TTM) is negative, PVH P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PVH FY 2026 (ended Feb 1, 2026) · OPK FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
PVH CORP. · implied price per share
Bear
-$21.14
Base
-$24.87
Bull
-$28.60
OPKO Health, Inc. · implied price per share
Bear
-$1.74
Base
-$2.04
Bull
-$2.35
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.48x
0.54x
Net debt / EBITDA
Leverage against operating earnings
3.21x
-3.43x
Cash and equivalents
Liquid reserves on the balance sheet
$701.50M
$368.94M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TAPESTRY, INC.
PVH vs TPR
RALPH LAUREN CORP
PVH vs RL
Kontoor Brands, Inc.
PVH vs KTB
GAP INC
PVH vs GAP
AMARIN CORP PLC\UK
PVH vs AMRN
Sarepta Therapeutics, Inc.
PVH vs SRPT
Amphastar Pharmaceuticals, Inc.
PVH vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
PVH vs SUPN
Harmony Biosciences Holdings, Inc.
PVH vs HRMY
$2.32B
$687.93M
Live quote
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
